Vabomere (Meropenem-Vaborbactam) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Vabomere. Always confirm against the full prescribing information.
100 interactions
Acenocoumarol
The risk or severity of bleeding can be increased when Meropenem is combined with Acenocoumarol.
Level 2 evidence
Amikacin
Meropenem may decrease the excretion rate of Amikacin which could result in a higher serum level.
Level 2 evidence
Amikacin
Vaborbactam may decrease the excretion rate of Amikacin which could result in a higher serum level.
Level 2 evidence
Articaine
The risk or severity of methemoglobinemia can be increased when Meropenem is combined with Articaine.
Level 1 evidence
Abacavir
Meropenem may decrease the excretion rate of Abacavir which could result in a higher serum level.
Level 2 evidence
Abacavir
Abacavir may decrease the excretion rate of Vaborbactam which could result in a higher serum level.
Level 2 evidence
Abatacept
Meropenem may increase the hepatotoxic activities of Abatacept.
Level 2 evidence
Abemaciclib
Meropenem may increase the hepatotoxic activities of Abemaciclib.
Level 2 evidence
Abiraterone
Abiraterone may increase the hepatotoxic activities of Meropenem.
Level 2 evidence
Acamprosate
Acamprosate may increase the hepatotoxic activities of Meropenem.
Level 2 evidence
Acarbose
Acarbose may increase the hepatotoxic activities of Meropenem.
Level 2 evidence
Acebutolol
Meropenem may increase the hepatotoxic activities of Acebutolol.
Vabomere (Meropenem-Vaborbactam) has 1321 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Vabomere (Meropenem-Vaborbactam) has 4 major, 64 moderate, and 1253 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Vabomere. Always confirm against the full prescribing information.